# ABLYSINOL
> **NDA207987** · New Drug Application · Sponsor: BPI LABS · Approved 2018-06-21
## Drug
- **FDA Application Number:** NDA207987
- **Application type:** New Drug Application
- **Brand name:** ABLYSINOL
- **Generic name:** ALCOHOL
- **Active ingredients:** DEHYDRATED ALCOHOL
- **Dosage form:** SOLUTION
- **Route:** INTRA-ARTERIAL
- **Marketing status:** Prescription
- **Sponsor:** BPI LABS
- **Manufacturer:** Ajenat Pharmaceuticals LLC
- **First approval:** 2018-06-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207987)
---
*AI Analytics · CC0 1.0*